Cargando…

Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients

Cardiovascular disease, closely related to an early appearance of hypertension, is the most common mortality cause among autosomal dominant polycystic kidney disease patients (ADPKD). The development of hypertension is related to an increase in renal volume. Whether the increasing in the renal volum...

Descripción completa

Detalles Bibliográficos
Autores principales: Sans, Laia, Pascual, Julio, Radosevic, Aleksandar, Quintian, Claudia, Ble, Mireia, Molina, Lluís, Mojal, Sergi, Ballarin, José A., Torra, Roser, Fernández-Llama, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266054/
https://www.ncbi.nlm.nih.gov/pubmed/27930582
http://dx.doi.org/10.1097/MD.0000000000005595
_version_ 1782500396666716160
author Sans, Laia
Pascual, Julio
Radosevic, Aleksandar
Quintian, Claudia
Ble, Mireia
Molina, Lluís
Mojal, Sergi
Ballarin, José A.
Torra, Roser
Fernández-Llama, Patricia
author_facet Sans, Laia
Pascual, Julio
Radosevic, Aleksandar
Quintian, Claudia
Ble, Mireia
Molina, Lluís
Mojal, Sergi
Ballarin, José A.
Torra, Roser
Fernández-Llama, Patricia
author_sort Sans, Laia
collection PubMed
description Cardiovascular disease, closely related to an early appearance of hypertension, is the most common mortality cause among autosomal dominant polycystic kidney disease patients (ADPKD). The development of hypertension is related to an increase in renal volume. Whether the increasing in the renal volume before the onset of hypertension leads to a major cardiovascular risk in ADPKD patients remains unknown. Observational and cross-sectional study of 62 normotensive ADPKD patients with normal renal function and a group of 28 healthy controls. Renal volume, blood pressure, and renal (urinary albumin excretion), blood vessels (carotid intima media thickness and carotid-femoral pulse wave velocity), and cardiac (left ventricular mass index and diastolic dysfunction parameters) asymptomatic organ damage were determined and were considered as continuous variables. Correlations between renal volume and the other parameters were studied in the ADPKD population, and results were compared with the control group. Blood pressure values and asymptomatic organ damage were used to assess the cardiovascular risk according to renal volume tertiles. Even though in the normotensive range, ADPKD patients show higher blood pressure and major asymptomatic organ damage than healthy controls. Asymptomatic organ damage is not only related to blood pressure level but also to renal volume. Multivariate regression analysis shows that microalbuminuria is only associated with height adjusted renal volume (htTKV). An htTKV above 480 mL/m represents a 10 times higher prevalence of microalbuminuria (4.8% vs 50%, P < 0.001). Normotensive ADPKD patients from the 2nd tertile renal volume group (htTKV > 336 mL/m) show higher urinary albumin excretion, but the 3rd tertile htTKV (htTKV > 469 mL/m) group shows the worst cardiovascular risk profile. Normotensive ADPKD patients show in the early stages of the disease with slight increase in renal volume, higher cardiovascular risk than healthy controls. An htTKV above 468 mL/m is associated with the greatest increase in cardiovascular risk of normotensive ADPKD patients with normal renal function. Early strategies to slow the progression of the cardiovascular risk of these patients might be beneficial in their long-term cardiovascular survival.
format Online
Article
Text
id pubmed-5266054
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-52660542017-02-06 Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients Sans, Laia Pascual, Julio Radosevic, Aleksandar Quintian, Claudia Ble, Mireia Molina, Lluís Mojal, Sergi Ballarin, José A. Torra, Roser Fernández-Llama, Patricia Medicine (Baltimore) 5200 Cardiovascular disease, closely related to an early appearance of hypertension, is the most common mortality cause among autosomal dominant polycystic kidney disease patients (ADPKD). The development of hypertension is related to an increase in renal volume. Whether the increasing in the renal volume before the onset of hypertension leads to a major cardiovascular risk in ADPKD patients remains unknown. Observational and cross-sectional study of 62 normotensive ADPKD patients with normal renal function and a group of 28 healthy controls. Renal volume, blood pressure, and renal (urinary albumin excretion), blood vessels (carotid intima media thickness and carotid-femoral pulse wave velocity), and cardiac (left ventricular mass index and diastolic dysfunction parameters) asymptomatic organ damage were determined and were considered as continuous variables. Correlations between renal volume and the other parameters were studied in the ADPKD population, and results were compared with the control group. Blood pressure values and asymptomatic organ damage were used to assess the cardiovascular risk according to renal volume tertiles. Even though in the normotensive range, ADPKD patients show higher blood pressure and major asymptomatic organ damage than healthy controls. Asymptomatic organ damage is not only related to blood pressure level but also to renal volume. Multivariate regression analysis shows that microalbuminuria is only associated with height adjusted renal volume (htTKV). An htTKV above 480 mL/m represents a 10 times higher prevalence of microalbuminuria (4.8% vs 50%, P < 0.001). Normotensive ADPKD patients from the 2nd tertile renal volume group (htTKV > 336 mL/m) show higher urinary albumin excretion, but the 3rd tertile htTKV (htTKV > 469 mL/m) group shows the worst cardiovascular risk profile. Normotensive ADPKD patients show in the early stages of the disease with slight increase in renal volume, higher cardiovascular risk than healthy controls. An htTKV above 468 mL/m is associated with the greatest increase in cardiovascular risk of normotensive ADPKD patients with normal renal function. Early strategies to slow the progression of the cardiovascular risk of these patients might be beneficial in their long-term cardiovascular survival. Wolters Kluwer Health 2016-12-09 /pmc/articles/PMC5266054/ /pubmed/27930582 http://dx.doi.org/10.1097/MD.0000000000005595 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 5200
Sans, Laia
Pascual, Julio
Radosevic, Aleksandar
Quintian, Claudia
Ble, Mireia
Molina, Lluís
Mojal, Sergi
Ballarin, José A.
Torra, Roser
Fernández-Llama, Patricia
Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
title Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
title_full Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
title_fullStr Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
title_full_unstemmed Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
title_short Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
title_sort renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
topic 5200
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266054/
https://www.ncbi.nlm.nih.gov/pubmed/27930582
http://dx.doi.org/10.1097/MD.0000000000005595
work_keys_str_mv AT sanslaia renalvolumeandcardiovascularriskassessmentinnormotensiveautosomaldominantpolycystickidneydiseasepatients
AT pascualjulio renalvolumeandcardiovascularriskassessmentinnormotensiveautosomaldominantpolycystickidneydiseasepatients
AT radosevicaleksandar renalvolumeandcardiovascularriskassessmentinnormotensiveautosomaldominantpolycystickidneydiseasepatients
AT quintianclaudia renalvolumeandcardiovascularriskassessmentinnormotensiveautosomaldominantpolycystickidneydiseasepatients
AT blemireia renalvolumeandcardiovascularriskassessmentinnormotensiveautosomaldominantpolycystickidneydiseasepatients
AT molinalluis renalvolumeandcardiovascularriskassessmentinnormotensiveautosomaldominantpolycystickidneydiseasepatients
AT mojalsergi renalvolumeandcardiovascularriskassessmentinnormotensiveautosomaldominantpolycystickidneydiseasepatients
AT ballarinjosea renalvolumeandcardiovascularriskassessmentinnormotensiveautosomaldominantpolycystickidneydiseasepatients
AT torraroser renalvolumeandcardiovascularriskassessmentinnormotensiveautosomaldominantpolycystickidneydiseasepatients
AT fernandezllamapatricia renalvolumeandcardiovascularriskassessmentinnormotensiveautosomaldominantpolycystickidneydiseasepatients